These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26119690)

  • 21. Characterization of multidrug-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from a paediatric clinic in China.
    Dong F; Xu XW; Song WQ; Lü P; Yu SJ; Yang YH; Shen XZ
    Chin Med J (Engl); 2008 Sep; 121(17):1611-6. PubMed ID: 19024085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of an imported extremely-resistant Pseudomonas aeruginosa producing three different extended-spectrum β-lactamases and hyperproducing two multidrug-efflux pumps.
    Ratkai C; Nagy E; Peixe L; Bertalan V; Hajdú E
    J Infect; 2010 Dec; 61(6):511-2. PubMed ID: 20951729
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients.
    Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Del Prete MS; Licci A; Riva A; Lukasiak J; Scalise G
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1249-52. PubMed ID: 15728942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of intravenous immunoglobulin G on the deposition of immunoglobulin G and C3 onto type III group B streptococcus and Escherichia coli K1.
    Lassiter HA; Robinson TW; Brown MS; Hall DC; Hill HR; Christensen RD
    J Perinatol; 1996; 16(5):346-51. PubMed ID: 8915932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
    Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
    Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.
    Nicholson A; Perry JD; James AL; Stanforth SP; Carnell S; Wilkinson K; Anjam Khan CM; De Soyza A; Gould FK
    Int J Antimicrob Agents; 2012 Jan; 39(1):27-32. PubMed ID: 21993484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity and pharmacodynamics of commonly used antibiotics against adult systemic isolates of Escherichia coli and Pseudomonas aeruginosa at Forty US Hospitals.
    Eagye KJ; Kuti JL; Sutherland CA; Christensen H; Nicolau DP
    Clin Ther; 2009 Nov; 31(11):2678-88. PubMed ID: 20110010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of extended-spectrum beta-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial.
    Hoban DJ; Bouchillon SK; Dowzicky MJ
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):423-8. PubMed ID: 17403448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Discovery of new structure of class 1 integron in MDR Pseudomonas aeruginosa and its association with drug-resistance].
    Zhu Y; Yi Y; Yang X; Lv N; Li J; Zhu B; Hu Y
    Wei Sheng Wu Xue Bao; 2013 Sep; 53(9):927-32. PubMed ID: 24377244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of multidrug-resistant Gram-negative infections in children.
    Hsu AJ; Tamma PD
    Clin Infect Dis; 2014 May; 58(10):1439-48. PubMed ID: 24501388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Opsonizing activity of human immunoglobulin preparations for intravenous use (IVIG)].
    Banach W; Bucholc B
    Med Dosw Mikrobiol; 1994; 46(4):349-55. PubMed ID: 7603135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli in an urban county hospital.
    Doernberg SB; Winston LG
    Am J Infect Control; 2012 Mar; 40(2):123-7. PubMed ID: 21775020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment potential of pathogen-reactive antibodies sequentially purified from pooled human immunoglobulin.
    Reglinski M; Sriskandan S
    BMC Res Notes; 2019 Apr; 12(1):228. PubMed ID: 30992057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
    Lee CI; Lee NY; Yan JJ; Lee HC; Ko NY; Chang CM; Wu CJ; Chen PL; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2009 Aug; 42(4):303-9. PubMed ID: 19949753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug resistance patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-2011.
    Haeili M; Ghodousi A; Nomanpour B; Omrani M; Feizabadi MM
    J Infect Dev Ctries; 2013 Apr; 7(4):312-7. PubMed ID: 23592640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diversity of β-lactamases produced by imipenem resistant, Pseudomonas aeruginosa isolates from the bloodstream.
    Najar Peerayeh S; Pirhajati Mahabadi R; Pakbaten Toupkanlou S; Siadat SD
    Burns; 2014 Nov; 40(7):1360-4. PubMed ID: 24513132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes.
    Ho PL; Wong RC; Yip KS; Loke SL; Leung MS; Mak GC; Chow FK; Tsang KW; Que TL;
    Diagn Microbiol Infect Dis; 2007 Dec; 59(4):439-45. PubMed ID: 17888610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Suto S; Zagar Z
    Int J Antimicrob Agents; 2005 Jun; 25(6):479-87. PubMed ID: 15894465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.